Real‐world utilization of EGFR TKIs and prognostic factors for survival in EGFR‐mutated non‐small cell lung cancer patients with brain metastases

X Yu, J Sheng, G Pan, Y Fan - International Journal of Cancer, 2021 - Wiley Online Library
Brain metastases (BMs) cause morbidity and mortality in patients with non‐small cell lung
cancer (NSCLC). The optimal management of epidermal growth factor receptor (EGFR) …
被引用次数：14 相关文章

Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases

X Yu, J Sheng, G Pan, Y Fan - International journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Brain metastases (BMs) cause morbidity and mortality in patients with non-small cell lung
cancer (NSCLC). The optimal management of epidermal growth factor receptor (EGFR) …

Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.

X Yu, J Sheng, G Pan, Y Fan - International Journal of Cancer, 2021 - europepmc.org
Brain metastases (BMs) cause morbidity and mortality in patients with non-small cell lung
cancer (NSCLC). The optimal management of epidermal growth factor receptor (EGFR) …

Real‐world utilization of EGFR TKIs and prognostic factors for survival in EGFR‐mutated non‐small cell lung cancer patients with brain metastases

X Yu, J Sheng, G Pan, Y Fan - International Journal of Cancer, 2021 - infona.pl
Brain metastases (BMs) cause morbidity and mortality in patients with non‐small cell lung
cancer (NSCLC). The optimal management of epidermal growth factor receptor (EGFR) …